Immunotech Biopharm Ltd
Company Profile
Business description
Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.
Contact
No.1 Kangding Street
8th Floor, Block 1, Guosheng Technology Park
Beijing Economic-technological Development Area
Beijing100176
CHNT: +86 8610884002
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
154
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,833.60 | 4.90 | 0.06% |
CAC 40 | 7,754.55 | 16.13 | 0.21% |
DAX 40 | 23,934.13 | 144.02 | 0.61% |
Dow JONES (US) | 44,828.53 | 344.11 | 0.77% |
FTSE 100 | 8,823.20 | 48.51 | 0.55% |
HKSE | 24,069.94 | 151.47 | -0.63% |
NASDAQ | 20,601.10 | 207.97 | 1.02% |
Nikkei 225 | 39,785.90 | 23.42 | 0.06% |
NZX 50 Index | 12,704.48 | 79.81 | -0.62% |
S&P 500 | 6,279.35 | 51.93 | 0.83% |
S&P/ASX 200 | 8,595.80 | 1.90 | -0.02% |
SSE Composite Index | 3,461.15 | 6.36 | 0.18% |